Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects
Long-term Follow-up (LTFU) Study of the Phase I/II Safety and Preliminary Efficacy Investigation of Intramedullary Spinal Cord Transplantation of HuCNS-SC® in Subjects With Thoracic (T2-T11) Spinal Cord Trauma
Sponsor: StemCells, Inc.
Terminated
Based on a business decision unrelated to any safety concerns.
Other terminated trials from StemCells, Inc.
- Age-Related Macular Degeneration · May 2016
- Cervical Spinal Cord Injury · Phase PHASE2 · May 2016
- Age-Related Macular Degeneration · Phase PHASE2 · May 2016
More terminations from StemCells, Inc.
A observational or N/A phase clinical study on Spinal Cord Injury, this trial is terminated or withdrawn. The trial is conducted by StemCells, Inc. and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- StemCells, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .